[Federal Register: January 9, 2003 (Volume 68, Number 6)]
[Notices]               
[Page 1178]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09ja03-24]                         


=======================================================================
-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE


Department of the Army


 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Transformed Bacteria 
Producing CS6 Antigens as Vaccines


AGENCY: Department of the Army, (DoD).


ACTION: Notice.


-----------------------------------------------------------------------


SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
09/479,877 entitled ``Transformed Bacteria Producing CS6 Antigens as 
Vaccines,'' file January 10, 2000. The United States Government, as 
represented by the Secretary of the Army, has rights in this invention.


ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.


FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.


SUPPLEMENTARY INFORMATION: This invention is related to a CS6 antigen 
for use in vaccines to protect from pathological effects of 
enterotoxigenic E. coli.


Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-435 Filed 1-8-03; 8:45 am]

BILLING CODE 3710-08-M